PUBLISHER: 360iResearch | PRODUCT CODE: 1609087
PUBLISHER: 360iResearch | PRODUCT CODE: 1609087
Molecular Methods Market by Technology (Biosensors, Immunoassay, Microarray), Product (Instrument, Reagents & Consumables, Services) - Global Forecast 2025-2030
The Molecular Methods Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.42 billion in 2024, and is projected to grow at a CAGR of 6.83%, to USD 3.64 billion by 2030.
The molecular methods market encompasses various techniques used in molecular biology, primarily focusing on the analysis of nucleic acids and proteins, to facilitate the detection, characterization, or quantification of biomarkers. These methods include polymerase chain reaction (PCR), sequencing technologies, microarrays, and other sophisticated biochemical methods that are essential across various sectors such as healthcare, agriculture, environmental studies, and pharmaceuticals. The necessity of molecular methods is driven by the growing demand for personalized medicine, targeted therapies, and advanced diagnostic tools aiming to enhance treatment efficacy and patient outcomes. Applications range from research and genomic studies to clinical diagnostics and pharmaceutical development. End-users include hospitals, research institutions, biotechnology firms, and agricultural industries, among others. Key growth factors influencing the market include technological advancements in sequencing and bioinformatics, the rise of precision medicine, and increased funding for genetic research. Additionally, the COVID-19 pandemic has underscored the importance of molecular diagnostics, accelerating market adoption. Potential opportunities lie in the expansion of CRISPR technology, development of next-generation sequencing (NGS) applications, and biomarker discovery. However, challenges such as high costs, regulatory hurdles, and the need for skilled personnel impede faster market growth. Innovation and research are best directed at automating molecular methods to reduce costs and improve accessibility, enhancing data analysis capabilities through AI, and exploring novel applications in synthetic biology and gene editing. The market's nature is dynamic, with significant opportunities for those who can navigate technological complexities and regulatory landscapes. Companies are advised to invest in partnerships and research collaborations to capitalize on emerging technologies and develop comprehensive solutions that serve both niche and broad applications, thereby aligning with future market demands.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 2.29 billion |
| Estimated Year [2024] | USD 2.42 billion |
| Forecast Year [2030] | USD 3.64 billion |
| CAGR (%) | 6.83% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Methods Market
The Molecular Methods Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing demand for food safety
- Rising prevalence of infectious diseases
- Increasing applications in environmental engineering
- Market Restraints
- Stringent regulatory norms for approval
- Market Opportunities
- Ongoing R&D and advancements in molecular techniques
- Rising developments in genomics filed
- Market Challenges
- Intrinsic limitations of molecular methods
Porter's Five Forces: A Strategic Tool for Navigating the Molecular Methods Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Methods Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Molecular Methods Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Methods Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Molecular Methods Market
A detailed market share analysis in the Molecular Methods Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Methods Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Methods Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Methods Market
A strategic analysis of the Molecular Methods Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Molecular Methods Market, highlighting leading vendors and their innovative profiles. These include 3m Company, Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd, HiMedia Laboratories LLC, Invitae Corporation, Neogen Corporation, QIAGEN GmbH, Sekisui Chemical Co., Ltd., SGS SA, Siemens AG, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Molecular Methods Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Technology, market is studied across Biosensors, Immunoassay, Microarray, and Polymerase Chain Reaction.
- Based on Product, market is studied across Instrument, Reagents & Consumables, and Services.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing demand for food safety
- 5.1.1.2. Rising prevalence of infectious diseases
- 5.1.1.3. Increasing applications in environmental engineering
- 5.1.2. Restraints
- 5.1.2.1. Stringent regulatory norms for approval
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing R&D and advancements in molecular techniques
- 5.1.3.2. Rising developments in genomics filed
- 5.1.4. Challenges
- 5.1.4.1. Intrinsic limitations of molecular methods
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Molecular Methods Market, by Technology
- 6.1. Introduction
- 6.2. Biosensors
- 6.3. Immunoassay
- 6.4. Microarray
- 6.5. Polymerase Chain Reaction
7. Molecular Methods Market, by Product
- 7.1. Introduction
- 7.2. Instrument
- 7.3. Reagents & Consumables
- 7.4. Services
8. Americas Molecular Methods Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Molecular Methods Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Molecular Methods Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. 3m Company
- 2. Abbott Laboratories
- 3. Bio-Rad Laboratories, Inc.
- 4. bioMerieux SA
- 5. Danaher Corporation
- 6. Eurofins Scientific
- 7. F. Hoffmann-La Roche Ltd
- 8. HiMedia Laboratories LLC
- 9. Invitae Corporation
- 10. Neogen Corporation
- 11. QIAGEN GmbH
- 12. Sekisui Chemical Co., Ltd.
- 13. SGS SA
- 14. Siemens AG
- 15. Thermo Fisher Scientific Inc.
LIST OF FIGURES
- FIGURE 1. MOLECULAR METHODS MARKET RESEARCH PROCESS
- FIGURE 2. MOLECULAR METHODS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. MOLECULAR METHODS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL MOLECULAR METHODS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. MOLECULAR METHODS MARKET DYNAMICS
- TABLE 7. GLOBAL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL MOLECULAR METHODS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL MOLECULAR METHODS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL MOLECULAR METHODS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL MOLECULAR METHODS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL MOLECULAR METHODS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL MOLECULAR METHODS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL MOLECULAR METHODS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 17. AMERICAS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 18. AMERICAS MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 19. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 20. ARGENTINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 21. BRAZIL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 22. BRAZIL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 23. CANADA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 24. CANADA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 25. MEXICO MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 26. MEXICO MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 27. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 28. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 29. UNITED STATES MOLECULAR METHODS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 30. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 31. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 32. ASIA-PACIFIC MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 33. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 34. AUSTRALIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 35. CHINA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 36. CHINA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 37. INDIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 38. INDIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 39. INDONESIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 40. INDONESIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 41. JAPAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 42. JAPAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 43. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 44. MALAYSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 45. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 46. PHILIPPINES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 47. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 48. SINGAPORE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 49. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 50. SOUTH KOREA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 51. TAIWAN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 52. TAIWAN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 53. THAILAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 54. THAILAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 55. VIETNAM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 56. VIETNAM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 57. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 58. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 59. EUROPE, MIDDLE EAST & AFRICA MOLECULAR METHODS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 60. DENMARK MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 61. DENMARK MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 62. EGYPT MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 63. EGYPT MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 64. FINLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 65. FINLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 66. FRANCE MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 67. FRANCE MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 68. GERMANY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 69. GERMANY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 70. ISRAEL MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 71. ISRAEL MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 72. ITALY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 73. ITALY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 74. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 75. NETHERLANDS MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 76. NIGERIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 77. NIGERIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 78. NORWAY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 79. NORWAY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 80. POLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 81. POLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 82. QATAR MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 83. QATAR MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 84. RUSSIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 85. RUSSIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 86. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 87. SAUDI ARABIA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 88. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 89. SOUTH AFRICA MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 90. SPAIN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 91. SPAIN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 92. SWEDEN MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 93. SWEDEN MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 95. SWITZERLAND MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 96. TURKEY MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 97. TURKEY MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 98. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 99. UNITED ARAB EMIRATES MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 100. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 101. UNITED KINGDOM MOLECULAR METHODS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 102. MOLECULAR METHODS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 103. MOLECULAR METHODS MARKET, FPNV POSITIONING MATRIX, 2023
